Related Experiment Video
Updated: Aug 12, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin
Grigorij Kogan1, Irina Sadovskaya, Philippe Chaignon
1Laboratoire de Recherche sur les Biomatériaux et les Biotechnologies INSERM ERI 002, Université du Littoral-Côte d'Opale, Boulogne-sur-mer, France.
Abstract:
Staphylococcus aureus and coagulase-negative staphylococci, primarily Staphylococcus epidermidis, are recognized as a major cause of nosocomial infections associated with the use of implanted medical devices. The capacity of S. epidermidis to form biofilms, allowing it to evade host immune defence mechanisms and antibiotic therapy, is considered to be crucial in colonizing the surfaces of medical implants and dissemination of infection. It has previously been demonstrated that the biofilm of a model strain S. epidermidis RP62A comprises two carbohydrate-containing moieties, a polysaccharide having a structure of a linear poly-N-acetyl-(1-->6)-beta-D-glucosamine and teichoic acid. In the present paper we show that, unlike this model strain, certain clinical isolates of coagulase-negative staphylococci produce biofilms that do not contain detectable amounts of poly-N-acetyl-(1-->6)-beta-D-glucosamine. In contrast to that of S. epidermidis RP62A, these biofilms are not detached with metaperiodate, while proteinase K causes their partial dispersal.
Insights
Certain coagulase-negative staphylococci form biofilms lacking poly-N-acetyl-(1-->6)-beta-D-glucosamine, a key component in Staphylococcus epidermidis biofilms. These biofilms exhibit different sensitivities to dispersal agents, impacting medical implant infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Biomaterials Science
Background:
- Coagulase-negative staphylococci, particularly Staphylococcus epidermidis, are significant causes of nosocomial infections linked to implanted medical devices.
- The ability of Staphylococcus epidermidis to form biofilms is critical for colonizing medical implants and evading host defenses and antibiotic treatments.
Purpose of the Study:
- To investigate the structural composition of biofilms produced by clinical isolates of coagulase-negative staphylococci.
- To compare the biofilm composition of clinical isolates with the well-characterized model strain Staphylococcus epidermidis RP62A.
Main Methods:
- Analysis of biofilm composition from clinical isolates of coagulase-negative staphylococci.
- Treatment of biofilms with metaperiodate and proteinase K to assess structural integrity and dispersal characteristics.
- Comparison of biofilm properties with the model strain Staphylococcus epidermidis RP62A.
Main Results:
- Certain clinical isolates of coagulase-negative staphylococci produce biofilms that lack detectable poly-N-acetyl-(1-->6)-beta-D-glucosamine.
- Unlike the model strain S. epidermidis RP62A, these biofilms are resistant to dispersal by metaperiodate.
- Proteinase K treatment results in partial dispersal of these alternative biofilms.
Conclusions:
- The composition of staphylococcal biofilms can vary among clinical isolates, with some lacking the previously identified polysaccharide component.
- These compositional differences influence biofilm resistance to chemical dispersal agents, suggesting diverse mechanisms in medical device-associated infections.
- Understanding these variations is crucial for developing targeted strategies against biofilm-related infections on medical implants.
More Related Videos
Related Concept Videos
Outer Layers of the Cell Envelope
Surface Appendages of Archaea
Biofilms
Colonisation of Pathogens
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance

